+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Biosimilar Interleukins Global Market Report 2024 - Product Thumbnail Image

Biosimilar Interleukins Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Biosimilar Lymphocyte Modulator Global Market Report 2024 - Product Thumbnail Image

Biosimilar Lymphocyte Modulator Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Biologic & Biosimilar RA Drugs Global Market Report 2024 - Product Thumbnail Image

Biologic & Biosimilar RA Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Metastatic Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
Lung Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Lung Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
From
From
From
Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2024 - Product Thumbnail Image

Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
Loading Indicator